HKSE - Delayed Quote HKD

WuXi XDC Cayman Inc. (2268.HK)

Compare
30.050
+0.600
+(2.04%)
At close: 4:08:28 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Dr. Jincai Li Ph.D. CEO & Executive Director 3.08M -- 1973
Mr. Xiaojie Xi Company Secretary, CFO & Executive Director 2.73M -- 1976
Mr. Jingwei Zhang COO & Executive Director 2.06M -- 1969
Dr. Meiying Zhu Chief Technology Officer -- -- 1966
Dr. Jianjun Luo Vice President -- -- 1968

WuXi XDC Cayman Inc.

No. 11 Xinhui Ring Road
Xinwu District
Wuxi
China
https://wuxixdc.com
Sector: 
Healthcare
Full Time Employees: 
1,496

Description

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.

Corporate Governance

WuXi XDC Cayman Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 25, 2025 at 10:59 AM UTC - April 1, 2025 at 12:00 PM UTC

WuXi XDC Cayman Inc. Earnings Date

Recent Events

Related Tickers

2359.HK WuXi AppTec Co., Ltd.
52.250
-3.51%
 
CHHL China Holdings, Inc.
0.0002
0.00%
 
NEOG Neogen Corporation
12.00
-5.03%
 
DHR Danaher Corporation
237.62
-0.94%